BG 6710 ROCKLEDGE DR. WING B RM 2150
6710B ROCKLEDGE DRIVE
BETHESDA MD 20817
Bill G. Kapogiannis, M.D., is a board-certified infectious disease specialist in pediatrics and internal medicine. He joined NICHD in 2005 and oversees the Adolescent Medicine Trials Network for HIV/AIDS Interventions, a multicenter U.S.-based research program that evaluates interventions for treatment and management of HIV infection and its complications among youth, as well as for the prevention of HIV transmission in the adolescent population, including HIV vaccine, microbicide, and pre-exposure prophylaxis (PrEP) studies. Dr. Kapogiannis is also the scientific director of the Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC3H) Consortium, which is researching optimal strategies to identify youth at risk of HIV infection and those living with HIV, and to enroll them into medical care programs across sub-Saharan Africa and in Brazil.
Dr. Kapogiannis’ research interests include studying how to improve access to and uptake of biomedical HIV prevention interventions, such as long-acting topical and systemic PrEP among at-risk youth, and how to optimize health outcomes on the HIV care continuum for youth living with HIV. He is also the executive secretary of the DHHS Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children, which issues the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children.
He received his M.D. from the University of Illinois at Chicago, College of Medicine, and completed a four-year internal medicine/pediatrics residency program at the University of Illinois at Chicago before finishing a combined fellowship training in infectious diseases within the departments of Internal Medicine and Pediatrics at Emory University, Atlanta, Georgia. Prior to joining NICHD, Dr. Kapogiannis' research involved assembling, collecting, and analyzing immunologic data on an adolescent cohort with HIV in Atlanta.